SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): August 5, 2003
MICROTEK MEDICAL HOLDINGS, INC.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Georgia
- --------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-24866 58-1746149
- ---------------------------- ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
512 Lehmberg Road; Columbus, Mississippi 39702
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices (Zip Code)
(662) 327-1863
(Registrant's Telephone Number, Including Area Code)
Item 7. Financial Statements and Exhibits
(c) Exhibits:
99.1 Press release dated August 5, 2003, reporting the Company's
second quarter 2003 results
Item 9. Regulation FD Disclosure (Including Item 12 Information)
On August 5, 2003, Microtek Medical Holdings, Inc. (the "Company")
issued a press release reporting the Company's financial results for
the quarter and six-month period ended June 30, 2003. This press
release is attached as Exhibit 99.1 to this report and is incorporated
herein by reference.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has caused this report to be duly signed on its behalf by the
undersigned hereunto duly authorized.
MICROTEK MEDICAL HOLDINGS, INC.
By: /s/ Dan R. Lee
------------------------------------------
Dan R. Lee, Chairman, President and
Chief Executive Officer
By: /s/ Roger G. Wilson
------------------------------------------
Roger G. Wilson, Chief Financial Officer
Dated: August 5, 2003
3
1640012v1